Close

Press Releases

Qatar Airways Cargo welcomes Envirotainer’s newest innovation: the Releye RAP

Qatar Airways Cargo approves Envirotainerโ€™s latest innovation โ€“ The Releyeยฎ RAP container. Officially launched on 9 February 2022, and able to accommodate 5 pallets, the Releyeยฎ RAP is the largest and most technically advanced product in Envirotainerโ€™s new generation...

Moderna Expands Global Footprint Through Commercial Partnership with Adium in Latin America

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced a distribution service agreement with Adium Pharma S.A., a leading private Latin American pharmaceutical company, to support the commercialization of the Moderna COVID-19 vaccine, Spikevax across...

Honeywell Teams With AstraZeneca To Develop Next-Generation Respiratory Inhalers That Use Near-Zero Global Warming Potential Propellant

Honeywell announced a commercial partnership with AstraZeneca to develop and bring to market next-generation respiratory inhalers that use near-zero global warming potential (GWP) propellants to treat asthma and chronic obstructive pulmonary disease (COPD). As many as 384 million people suffer...

BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Against Cancer

BioNTech SE and Medigene AG, a clinical-stage immuno-oncology company focusing on the development of T cell immunotherapies, announced that they have entered a multi-target research collaboration to develop T cell receptor (TCR) based immunotherapies against cancer. The initial term...

Quotient Sciences completes integration of drug substance into Translational Pharmaceutics Platform

Quotient Sciences โ€“ a global drug development and manufacturing accelerator offering a suite of services to clients in the pharmaceutical and biotech industry โ€“ announces that it has integrated drug substance into its flagship Translational Pharmaceuticsยฎ platform. The newly...

Northwest Biotherapeutics Announces Commencement Of Cancer Vaccine Production At Its Sawston, UK Facility

Northwest Biotherapeutic, a biotechnology company developing DCVaxยฎ personalized immune therapies for solid tumor cancers, announced commencement of production of its first dendritic cell cancer vaccine for a compassionate use patient at its recently licensed production facility in Sawston, UK. This...

ImmunoGen Announces a Global, Multi-Target License Agreement of its Novel Camptothecin ADC Platform to Lilly for Up to $1.7 Billion

ImmunoGen Inc., a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, announced a global, multi-year definitive licensing agreement whereby it granted Eli Lilly and Company (Lilly) exclusive rights to research, develop, and commercialize...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป